MS Speaks

Multiple Sclerosis => MS - RESEARCH AND NEWS => Topic started by: agate on April 26, 2019, 06:48:34 am

Title: Beta interferon drugs for MS seem to prolong life for over 30% of persons w/RRMS
Post by: agate on April 26, 2019, 06:48:34 am

This study is concerned with all of the interferon drugs in use for MS (interferon beta 1a and interferon beta 1b)--like Betaseron, Avonex, Rebif --"Common treatment for multiple sclerosis may prolong life" from the UBC News (March 18, 2019).


https://news.ubc.ca/2019/03/18/common-treatment-for-multiple-sclerosis-may-prolong-life/


The study subjects were people with relapsing-onset MS--they either had RRMS or had SPMS that had had a relapsing onset.


The original article in Brain (March 18, 2019)--"Multiple sclerosis: Effect of beta interferon treatment on survival":


https://academic.oup.com/brain/advance-article/doi/10.1093/brain/awz055/5382233